Journal of labelled compounds & radiopharmaceuticals最新文献

筛选
英文 中文
Carbon-14 Labeling Synthesis of RORγt Inhibitor JNJ-61803534 RORγt 抑制剂 JNJ-61803534 的碳 14 标记合成。
IF 0.9 4区 医学
Journal of labelled compounds & radiopharmaceuticals Pub Date : 2024-05-27 DOI: 10.1002/jlcr.4114
Fengbin Song, Rhys Salter, Lu Chen
{"title":"Carbon-14 Labeling Synthesis of RORγt Inhibitor JNJ-61803534","authors":"Fengbin Song,&nbsp;Rhys Salter,&nbsp;Lu Chen","doi":"10.1002/jlcr.4114","DOIUrl":"10.1002/jlcr.4114","url":null,"abstract":"<div>\u0000 \u0000 <p>Carbon-14 labeling synthesis of RORγt inhibitor JNJ-61803534 (<b>1</b>) was accomplished in four steps with the C14 label located at the thiazole-2-carboxamide carbon. The synthesis featured a highly efficient conversion of nitrile [<sup>14</sup>C]-<b>12</b> to ester [<sup>14</sup>C]-<b>17</b> under mild conditions via an imidate intermediate, overcoming the unsuccessful direct hydrolysis of nitrile <b>12</b> under either acidic or basic conditions. Since carbon-14 labeling via [<sup>14</sup>C]-nitrile installation and subsequent conversion to [<sup>14</sup>C]-carboxylic acid derivatives is a common labeling strategy, an efficient conversion of a nitrile to an ester under mild conditions could be of use for the future C14 labeling syntheses.</p>\u0000 </div>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Routine 89Zr-Immuno-PET Applications: Mild Iron Removal Can Favor the Use of Fe-DFO-N-suc-TFP Ester Over p-NCS-Bz-DFO 改进 89Zr-Immuno-PET 的常规应用:轻度除铁有利于使用 Fe-DFO-N-suc-TFP 酯而不是 p-NCS-Bz-DFO。
IF 0.9 4区 医学
Journal of labelled compounds & radiopharmaceuticals Pub Date : 2024-05-14 DOI: 10.1002/jlcr.4097
Thomas E. Wuensche, Sabine Nauta, Guus A. M. S. van Dongen, Danielle J. Vugts
{"title":"Improving Routine 89Zr-Immuno-PET Applications: Mild Iron Removal Can Favor the Use of Fe-DFO-N-suc-TFP Ester Over p-NCS-Bz-DFO","authors":"Thomas E. Wuensche,&nbsp;Sabine Nauta,&nbsp;Guus A. M. S. van Dongen,&nbsp;Danielle J. Vugts","doi":"10.1002/jlcr.4097","DOIUrl":"10.1002/jlcr.4097","url":null,"abstract":"<p>A key aspect for the applicability of <sup>89</sup>Zr-radioimmunoconjugates is inert modification and radiolabeling. The two commercially available bifunctional variants of the siderophore desferrioxamine (DFO), Fe-DFO-<i>N</i>-suc-TFP-ester and <i>p</i>-NCS-Bz-DFO, are most often used for clinical <sup>89</sup>Zr-immuno-PET. The use of Fe-DFO-<i>N</i>-suc-TFP-ester is advantageous with regard to higher radiolysis stability and more facile assessment of radiochemical purity as well as chelator-to-mAb ratio. However, not all mAbs withstand the Fe-removal step at relatively low pH (4–4.5) using EDTA, which is needed after conjugation to allow <sup>89</sup>Zr labeling. In this study, it was investigated whether hydroxybenzyl ethylenediamine (HBED) or the clinically approved deferiprone (DFP) can serve as an alternative for EDTA to establish a pH-independent mild method for Fe-removal and thereby broaden the applicability of Fe-DFO-<i>N</i>-suc-TFP-ester. Carrier-added [<sup>59</sup>Fe]Fe-DFO-<i>N</i>-suc-TFP-ester was used for mAb modification to enable direct tracking of the Fe-removal efficiency under various conditions. Whereas incomplete Fe-removal with HBED was observed at pH 5 or higher, Fe-removal with DFP was possible at a broad pH range (4–9). This provides a mild, pH-independent method for Fe-removal, improving the applicability and attractiveness of Fe-DFO-<i>N</i>-suc-TFP-ester for <sup>89</sup>Zr-mAb preparation.</p>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jlcr.4097","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140922445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis of Radiolabeled [14C]Rimsulfuron and Stable Isotope Labeled Rimsulfuron-[M + 3] to Support Crop Metabolism Studies for Reregistration 合成放射性标记的[14C]嘧磺隆和稳定同位素标记的嘧磺隆[M + 3],以支持重新登记的作物代谢研究。
IF 1.8 4区 医学
Journal of labelled compounds & radiopharmaceuticals Pub Date : 2024-05-06 DOI: 10.1002/jlcr.4096
Lindsey G. Horty, Timothy Martin
{"title":"Synthesis of Radiolabeled [14C]Rimsulfuron and Stable Isotope Labeled Rimsulfuron-[M + 3] to Support Crop Metabolism Studies for Reregistration","authors":"Lindsey G. Horty,&nbsp;Timothy Martin","doi":"10.1002/jlcr.4096","DOIUrl":"10.1002/jlcr.4096","url":null,"abstract":"<div>\u0000 \u0000 <p>Rimsulfuron is a sulfonylurea herbicide that controls grass and broadleaf weeds in maize, potatoes, fruits, nuts, and other crops. It can also be used as a burndown herbicide to clear invasive weed species along roadsides and other nonagricultural land. Rimsulfuron acts as an acetolactase synthase (ALS) inhibitor, blocking the synthesis of essential amino acids required for plant growth. As is common practice, rimsulfuron has been subject to periodic reviews by regulatory agencies for reregistration since its introduction into the market in the early 1990s. The goal of these reviews is to ensure that the herbicide carries out its intended use without creating adverse side effects to humans and the environment. Since scientific methods are continually evolving and being developed, global regulatory agencies can require additional studies to address data gaps for pesticide renewals. During this reregistration process for rimsulfuron, a new confined rotational crop study was required to address a data gap requested by the European Food Safety Authority (EFSA). Consequently, the corresponding pyridine and pyrimidine radiolabeled [<sup>14</sup>C]rimsulfuron and [M + 3] stable isotopes of rimsulfuron were synthesized for this study to support the reregistration process.</p>\u0000 </div>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140864983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficient Reductive N-11C-Methylation Using Arylamines or Alkylamines and In Situ–Generated [11C]Formaldehyde From [11C]Methyl Iodide 使用芳基胺或烷基胺进行高效的 N-11C 甲基化还原反应,以及由 [11C]Methyl Iodide 原位生成 [11C]Formaldehyde
IF 1.8 4区 医学
Journal of labelled compounds & radiopharmaceuticals Pub Date : 2024-05-04 DOI: 10.1002/jlcr.4095
Tatsuya Kikuchi, Toshimitsu Okamura, Ming-Rong Zhang
{"title":"Efficient Reductive N-11C-Methylation Using Arylamines or Alkylamines and In Situ–Generated [11C]Formaldehyde From [11C]Methyl Iodide","authors":"Tatsuya Kikuchi,&nbsp;Toshimitsu Okamura,&nbsp;Ming-Rong Zhang","doi":"10.1002/jlcr.4095","DOIUrl":"10.1002/jlcr.4095","url":null,"abstract":"<div>\u0000 \u0000 <p>Reductive <i>N</i>-<sup>11</sup>C-methylation using [<sup>11</sup>C]formaldehyde and amines has been used to prepare <i>N</i>-<sup>11</sup>C-methylated compounds. However, the yields of the <i>N</i>-<sup>11</sup>C-methylated compounds are often insufficient. In this study, we developed an efficient method for base-free reductive <i>N</i>-<sup>11</sup>C-methylation that is applicable to a wide variety of substrates, including arylamines bearing electron-withdrawing and electron-donating substituents. A 2-picoline borane complex, which is a stable and mild reductant, was used. Dimethyl sulfoxide was used as the primary reaction solvent, and glacial acetic acid or aqueous acetic acid was used as a cosolvent. While reductive <i>N</i>-<sup>11</sup>C-methylation efficiently proceeded under anhydrous conditions in most cases, the addition of water to the reductive <i>N</i>-<sup>11</sup>C-methylation generally increased the yield of the <i>N</i>-<sup>11</sup>C-methylated compounds. Substrates with hydroxy, carboxyl, nitrile, nitro, ester, amide, and phenone moieties and amine salts were applicable to the reaction. This proposed method for reductive <i>N</i>-<sup>11</sup>C-methylation should be applicable to a wide variety of substrates, including thermo-labile and base-sensitive compounds because the reaction was performed under relatively mild conditions (70°C) without the need for a base.</p>\u0000 </div>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140829326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
11C-Carbonylation for PET Imaging and Drug Discovery 用于 PET 成像和药物发现的 11C 碳酰化技术
IF 1.8 4区 医学
Journal of labelled compounds & radiopharmaceuticals Pub Date : 2024-05-01 DOI: 10.1002/jlcr.4094
Kenneth Dahl
{"title":"11C-Carbonylation for PET Imaging and Drug Discovery","authors":"Kenneth Dahl","doi":"10.1002/jlcr.4094","DOIUrl":"10.1002/jlcr.4094","url":null,"abstract":"","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140829324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis of Deuterated Endochin-Like Quinolones 氘代内脏类喹诺酮的合成。
IF 1.8 4区 医学
Journal of labelled compounds & radiopharmaceuticals Pub Date : 2024-04-25 DOI: 10.1002/jlcr.4092
Sovitj Pou, Rolf W. Winter, Katherine M. Liebman, Rosie A. Dodean, Aaron Nilsen, Andrea DeBarber, J. Stone Doggett, Michael K. Riscoe
{"title":"Synthesis of Deuterated Endochin-Like Quinolones","authors":"Sovitj Pou,&nbsp;Rolf W. Winter,&nbsp;Katherine M. Liebman,&nbsp;Rosie A. Dodean,&nbsp;Aaron Nilsen,&nbsp;Andrea DeBarber,&nbsp;J. Stone Doggett,&nbsp;Michael K. Riscoe","doi":"10.1002/jlcr.4092","DOIUrl":"10.1002/jlcr.4092","url":null,"abstract":"<div>\u0000 \u0000 <p>Malaria continues to be a serious and debilitating disease. The emergence and spread of high-level resistance to multiple antimalarial drugs by <i>Plasmodium falciparum</i> has brought about an urgent need for new treatments that will be active against multidrug resistant malaria infections. One such treatment, <b>ELQ-331</b> (MMV-167), an alkoxy carbonate prodrug of 4(1<i>H</i>)-quinolone <b>ELQ-300</b>, is currently in preclinical development with the Medicines for Malaria Venture. Clinical development of <b>ELQ-331</b> or similar compounds will require the availability of isotopically labeled analogs. Unfortunately, a suitable method for the deuteration of these important compounds was not found in the literature. Here, we describe a facile and scalable method for the deuteration of 4(1<i>H</i>)-quinolone <b>ELQ-300</b>, its alkoxycarbonate prodrug <b>ELQ-331</b>, and their respective N-oxides using deuterated acetic acid.</p>\u0000 </div>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140656307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Improved HPLC Separation Method for TSPO Radioligand [11C]ER176 Clinical Production 一种用于 TSPO 放射性配体 [11C]ER176 临床生产的改进型 HPLC 分离方法
IF 1.8 4区 医学
Journal of labelled compounds & radiopharmaceuticals Pub Date : 2024-04-19 DOI: 10.1002/jlcr.4093
Kang-Po Li, Hancheng Cai
{"title":"An Improved HPLC Separation Method for TSPO Radioligand [11C]ER176 Clinical Production","authors":"Kang-Po Li,&nbsp;Hancheng Cai","doi":"10.1002/jlcr.4093","DOIUrl":"10.1002/jlcr.4093","url":null,"abstract":"<div>\u0000 \u0000 <p>Mitochondrial membrane translocator protein 18 kDa (TSPO) expression is increased in activated microglia, established as a plausible target of neuroinflammation imaging. [<sup>11</sup>C]ER176, specifically binding to TSPO, has been developed as the third generation of radioligand for PET imaging of TSPO, which showed the potential in better quantifying neuroinflammation than its predecessors. In the current study, we developed an automated radiosynthesis with an improved HPLC purification method for [<sup>11</sup>C]ER176 clinical production. The improved HPLC separation was integrated into the automated production of [<sup>11</sup>C]ER176 using a reverse phase semi-preparative HPLC column with an isocratic pump and the mixture of methanol and 50 mM ammonium acetate as the mobile phase. The fraction corresponding to [<sup>11</sup>C]ER176 was collected around 8.5–9.0 min without the risk of getting contaminations from nearby impurities. The automated production process took about 30 min after end of bombardment (EOB) and the quality of the final product [<sup>11</sup>C]ER176 met all specifications for clinical use based on current US Pharmacopeia and FDA CGMP requirements.</p>\u0000 </div>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140626778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carbon 14 and Carbon 13 Syntheses of Velagliflozin 碳 14 和碳 13 合成 Velagliflozin
IF 1.8 4区 医学
Journal of labelled compounds & radiopharmaceuticals Pub Date : 2024-04-11 DOI: 10.1002/jlcr.4091
Bachir Latli, Matt J. Hrapchak, Maxim Chevliakov, Chutian Shu
{"title":"Carbon 14 and Carbon 13 Syntheses of Velagliflozin","authors":"Bachir Latli,&nbsp;Matt J. Hrapchak,&nbsp;Maxim Chevliakov,&nbsp;Chutian Shu","doi":"10.1002/jlcr.4091","DOIUrl":"10.1002/jlcr.4091","url":null,"abstract":"<div>\u0000 \u0000 <p>Velagliflozin is the active ingredient of the first oral liquid medication approved by the Food and Drug Administration for the treatment of diabetes in cats. This compound belongs to the known class of sodium-glucose cotransporter 2 inhibitors approved to treat diabetes in human. Here, we report the detailed synthesis of velagliflozin labeled with carbon 14 and carbon 13.</p>\u0000 </div>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140585843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparation, Characterization, and Radiolabeling of Anti-HER2 scFv With Technetium Tricarbonyl and Stability Studies 三羰基锝抗 HER2 scFv 的制备、表征、放射性标记及稳定性研究
IF 1.8 4区 医学
Journal of labelled compounds & radiopharmaceuticals Pub Date : 2024-03-14 DOI: 10.1002/jlcr.4090
Negar Bozorgchami, Maryam Ahmadzadeh, Dara Hatamabadi, Abdolreza Yazdani, Soraya Shahhosseini, Elham Mohit
{"title":"Preparation, Characterization, and Radiolabeling of Anti-HER2 scFv With Technetium Tricarbonyl and Stability Studies","authors":"Negar Bozorgchami,&nbsp;Maryam Ahmadzadeh,&nbsp;Dara Hatamabadi,&nbsp;Abdolreza Yazdani,&nbsp;Soraya Shahhosseini,&nbsp;Elham Mohit","doi":"10.1002/jlcr.4090","DOIUrl":"10.1002/jlcr.4090","url":null,"abstract":"<div>\u0000 \u0000 <p>Breast cancer is the most common diagnosed cancer, and the second cause of cancer death among women, worldwide. HER2 overexpression occurred in approximately 15% to 20% of breast cancers. Invasive biopsy method has been used for detection of HER2 overexpression. HER2-targeted imaging via an appropriate radionuclide is a promising method for sensitive and accurate identification of HER2<sup>+</sup> primary and metastatic lesions. <sup>99m</sup>Tc-anti-HER2 scFv can specifically target malignancies and be used for diagnosis of the cancer type and metastasis as well as treatment of breast cancer. We radiolabeled anti-HER2 scFv that was expressed in <i>Escherichia coli</i> and purified through Ni-NTA resin under native condition with <sup>99m</sup>Tc-tricarbonyl formed from boranocarbonate. HER2-based ELISA, BCA, TLC, and HPLC were used in this study. In the current study, anti-HER2 scFv was lyophilized before radiolabeling. It was found that freeze-drying did not change the binding activity of anti-HER2 scFv to HER2. Results demonstrated direct anti-HER2 scFv radiolabeling by <sup>99m</sup>Tc-tricarbonyl to hexahistidine sequence (His-tag) without any changes in biological activity and radiochemical purity of around 98%. Stability analysis revealed that <sup>99m</sup>Tc-anti-HER2 scFv is stable for at least 24 h in PBS buffer, normal saline, human plasma proteins, and histidine solution.</p>\u0000 </div>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis of Stable Isotope, Tritiated, and Carbon-14 Labeled Balcinrenone 合成稳定同位素、三联苯和碳-14 标记的 Balcinrenone。
IF 1.8 4区 医学
Journal of labelled compounds & radiopharmaceuticals Pub Date : 2024-03-05 DOI: 10.1002/jlcr.4089
Jonas Bergare, Christopher Bailey, Henrik Sörensen, Gunnar Grönberg, Karl Broberg, Monica Berglund, Tudor Grecu, Carolina Sanchez, Hans Emtenäs, Ryan A. Bragg, Charles S. Elmore
{"title":"Synthesis of Stable Isotope, Tritiated, and Carbon-14 Labeled Balcinrenone","authors":"Jonas Bergare,&nbsp;Christopher Bailey,&nbsp;Henrik Sörensen,&nbsp;Gunnar Grönberg,&nbsp;Karl Broberg,&nbsp;Monica Berglund,&nbsp;Tudor Grecu,&nbsp;Carolina Sanchez,&nbsp;Hans Emtenäs,&nbsp;Ryan A. Bragg,&nbsp;Charles S. Elmore","doi":"10.1002/jlcr.4089","DOIUrl":"10.1002/jlcr.4089","url":null,"abstract":"<div>\u0000 \u0000 <p>As part of a medicinal chemistry program aimed at discovering a mineralocorticoid receptor modulator for treatment of kidney and cardiovascular indications, multiple labeled versions of the lead compound, balcinrenone (AZD9977), were prepared. Four stable isotope labeled versions of the compound were prepared for clinical bioanalysis and biological investigations. Three of these stable isotope labeled compounds were tritiated as well as the parent for biology applications and DMPK investigations. They were prepared using a standard iodination–tritiodehalogentation approach. Finally, AZD9977 was prepared in carbon-14 labeled form for preclinical and clinical applications.</p>\u0000 </div>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140039602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信